Solid-Phase Synthesis of the Lipopeptide Myr-HBVpreS/2-78, a Hepatitis B Virus Entry Inhibitor

Chronic HBV infection is the leading cause of liver cirrhosis and hepatocellular carcinoma (HCC). Synthetic peptides derived from the N-terminus of the large HBV envelope protein (L-protein) have been shown to efficiently block HBV entry. Myr-HBVpreS/2-78, the parent compound of these drugs, inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales: Schieck, Alexa, Müller, Thomas, Schulze, Andreas, Haberkorn, Uwe, Urban, Stephan, Mier, Walter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2010
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257642/
https://www.ncbi.nlm.nih.gov/pubmed/20657392
http://dx.doi.org/10.3390/molecules15074773

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257642/
https://www.ncbi.nlm.nih.gov/pubmed/20657392
http://dx.doi.org/10.3390/molecules15074773

Ejemplares similares